Board meet on 26 October 2026 to approve September quarter and half year results
Board meeting fixed for Monday, 26 October 2026.
By ScoutQuest · · 2 min read
- Board meeting date
- Monday, 26 October 2026
- Agenda period
- quarter and half year ended 30 September 2026
- Trading window
- closed from 1 October 2026; stays closed till 48 hours after the results are declared
What the notice says
Eris Lifesciences has informed BSE and NSE that a meeting of its Board of Directors is scheduled on Monday, 26 October 2026. The notice is dated 19 October 2026.
- The board will, inter alia, consider and approve the standalone and consolidated unaudited financial results of the company for the quarter and half year ended 30 September 2026.
- Because the period covered is a quarter as well as a half year, the numbers will reflect both the three-month stretch and the six-month stretch of the current financial year.
- Both standalone and consolidated results are on the agenda, so the group-level numbers will also come with the standalone view.
Why investors watch this date
A board meeting to approve results is the point at which a listed company's earnings for the period are formally taken on record and then published. Until that happens, the market is working off the previous period's numbers and any other disclosures the company has made.
- The results that follow this meeting will carry the revenue, profit and margin figures for the September quarter and half year.
- They will also show how the business performed in the first six months of the financial year.
- This notice itself does not contain any financial figures; it fixes the date on which they will be considered.
Trading window
Separately, the company said that, as informed by its letter dated 28 September 2026, the trading window has already been closed from 1 October 2026.
- It will remain closed till 48 hours after the declaration of the financial results.
- The closure is under the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's own code of conduct for designated persons and their immediate relatives.
For a retail investor, a closed trading window is a routine feature around results season and applies to the people the code covers.
A point to note
- The exchange headline circulated with this notice refers to the period ended 30 June 2026, while the company's own notice states the quarter and half year ended 30 September 2026.
How to read this
This is a scheduling notice. The perception it can create is simply that the company is following its usual results calendar and has set a firm date. What actually moves the assessment of the business is the set of numbers that comes out after the board meets on 26 October 2026.
Also from Eris Lifesciences
Eris Lifesciences schedules Q2 & H1 FY2027 earnings call for October 26, 2026 at 4:30 PM IST
19 Oct 2026
Board meeting on 26 October 2026 to approve unaudited results for quarter and half year ended 30 September 2026
19 Oct 2026
More numbers
- Trading window closure period after declaration of results48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.